Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

5-HT Radiotracers

Financiado

Cerrado

Development of New PET tracers for in vivo 5 HT2A and 5 HT7 Brain Imaging

Disturbances in the serotonin (5-HT) transmitter system are seen in many neuropsychiatric disorders and brain disorders cause approximately one-third of the burden of illness in Europe. The aim of our proposal is to develop tools... ver más

28/02/2013

UCPH

220K€

Presupuesto del proyecto: 220K€

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-02-28 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UCPH

0.00€ | Lider

Proyectos interesantes

HumanNeuronScreen

Medical Technol...

Data Science

150K€ Cerrado

TACtIK

Medical Technol...

Data Science

213K€ Cerrado

SAF2009-09020

Medical Technol...

Applied Physics

99K€ Cerrado

CSIC13-4E-1699

Medical Technol...

Data Science

47K€ Cerrado

CTQ2014-52213-R

Medical Technol...

Data Science

116K€ Cerrado

TIVMOAN5FP

Medical Technol...

Data Science

200K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 220K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Disturbances in the serotonin (5-HT) transmitter system are seen in many neuropsychiatric disorders and brain disorders cause approximately one-third of the burden of illness in Europe. The aim of our proposal is to develop tools for in vivo imaging of the human brain with particular focus on the 5-HT7 and the 5-HT2A receptor. Both the 5-HT7 and 5-HT2A receptors are recognised as being involved in the pathophysiology of brain disorders and are also important drug targets. Today, no suitable PET radiotracer exists for 5-HT7 receptor brain imaging, but access to such a radiotracer would enable new groundbreaking discoveries in human brain disorders. It would also allow the pharmaceutical industry to assess their compounds’ blood-brain barrier penetration and receptor occupancy in humans prior to clinical trials and thereby importantly guide the choice of drug dose. With the development of our promising 5-HT2A receptor agonist [11C]Cimbi-36 we will explore the exciting prospects of its ability to image the brain’s own 5-HT release under pharmacological and functional challenges. Our last goal is to develop a general method for 18F-labelling of aromatic rings that could expand the possibilities for 18-F radiolabelling with this longer-lived radioisotope and thereby enable dissemination throughout Europe to complete, e.g., multi-center studies with productions in a few European centres. On a world-wide scale, there is a severe shortage of skilled and experienced PET radiochemists. The steeply increasing numbers of PET centres throughout Europe has generated an urgent and unmet need for the type of cross-disciplinary skills that will be provided through the planned training programme. The project has been initiated and the concepts tested over the last 9 months. This has enabled us to improve the research project further and to develop a pertinent contingency plan. Thus, we find that the timing to carry out the project is just right now.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores